Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Aura Biosciences (AURA) Other Non Operating Income (2021 - 2026)

Aura Biosciences filings provide 6 years of Other Non Operating Income readings, the most recent being $2000.0 for Q1 2026.

  • Quarterly Other Non Operating Income rose 108.33% to $2000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Mar 2026, up 51.93% year-over-year, with the annual reading at $1.8 million for FY2025, 50.84% up from the prior year.
  • Other Non Operating Income hit $2000.0 in Q1 2026 for Aura Biosciences, down from $1.9 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $1.9 million in Q4 2025 and bottomed at -$329000.0 in Q3 2022.
  • Average Other Non Operating Income over 5 years is $169882.4, with a median of -$24000.0 recorded in 2025.
  • The largest annual shift saw Other Non Operating Income crashed 732.69% in 2022 before it skyrocketed 4973.08% in 2024.
  • Aura Biosciences' Other Non Operating Income stood at $310000.0 in 2022, then crashed by 108.39% to -$26000.0 in 2023, then skyrocketed by 4973.08% to $1.3 million in 2024, then soared by 46.65% to $1.9 million in 2025, then crashed by 99.89% to $2000.0 in 2026.
  • Per Business Quant, the three most recent readings for AURA's Other Non Operating Income are $2000.0 (Q1 2026), $1.9 million (Q4 2025), and -$13000.0 (Q3 2025).